【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Ocular Hypertension Overview 9
Therapeutics Development 10
Pipeline Products for Ocular Hypertension – Overview 10
Pipeline Products for Ocular Hypertension – Comparative Analysis 11
Ocular Hypertension – Therapeutics under Development by Companies 12
Ocular Hypertension – Therapeutics under Investigation by Universities/Institutes 14
Ocular Hypertension – Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Ocular Hypertension – Products under Development by Companies 18
Ocular Hypertension – Products under Investigation by Universities/Institutes 19
Ocular Hypertension – Companies Involved in Therapeutics Development 20
Aerie Pharmaceuticals, Inc. 20
Allergan, Inc. 21
Amakem NV 22
Asahi Kasei Pharma Corp. 23
Bausch & Lomb Incorporated 24
Can-Fite BioPharma Ltd. 25
F. Hoffmann-La Roche Ltd. 26
Inotek Pharmaceuticals Corporation 27
Merck & Co., Inc. 28
Ocular Therapeutix, Inc. 29
Ono Pharmaceutical Co., Ltd. 30
Otsuka Holdings Co., Ltd. 31
Santen Pharmaceutical Co., Ltd. 32
Sylentis S.A. 33
Ocular Hypertension – Therapeutics Assessment 34
Assessment by Monotherapy Products 34
Assessment by Combination Products 35
Assessment by Target 36
Assessment by Mechanism of Action 38
Assessment by Route of Administration 40
Assessment by Molecule Type 42
Drug Profiles 44
(bimatoprost + brimonidine tartrate) – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
(carteolol hydrochloride + latanoprost) – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
(dorzolamide hydrochloride + latanoprost) – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
(latanoprost + trabodenoson) – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
(tafluprost + timolol maleate) – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
AMA-0076 – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
AR-13324 – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
ATS-8535 – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
bamosiran – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
bimatoprost SR – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
CF-101 – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
DE-117 – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
dorzolamide hydrochloride nanoparticle – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
Gene Therapy for Steroid Induced Glaucoma and Ocular Hypertension – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
latanoprost – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
latanoprost – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
latanoprost SR – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
latanoprostene bunod – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
lomerizine – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
ONO-9054 – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
OPA-6566 – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
RO-5093151 – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
tafluprost – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
trabodenoson – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
travoprost SR – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
Ocular Hypertension – Recent Pipeline Updates 76
Ocular Hypertension – Dormant Projects 90
Ocular Hypertension – Discontinued Products 92
Ocular Hypertension – Product Development Milestones 94
Featured News & Press Releases 94
Jan 12, 2015: Aerie Pharmaceuticals Announces Acceleration of Expected Timeline for Reporting Efficacy Results from Phase 3 Registration Trial (“Rocket 1″) of Rhopressa 94
Nov 25, 2014: Santen Launches TAPCOM Combination Ophthalmic Solution For The Treatment Of Glaucoma And Ocular Hypertension 95
Nov 12, 2014: Ocular Therapeutix Enrolls First Patients in Phase 2b Clinical Trial for Sustained Release Travoprost for the Treatment of Glaucoma and Ocular Hypertension 95
Oct 22, 2014: Santen Announces Positive Outcome of the European Decentralized Procedure for Approval of TAPTIQOM 96
Mar 10, 2014: Inotek Pharmaceuticals Initiates Phase 2 Study with Trabodenoson in Combination with Latanoprost for Patients with Glaucoma or Ocular Hypertension 97
Oct 10, 2013: Santen Announces the Launch of TAPROS MINI Ophthalmic Solution 0.0015% for Glaucoma and Ocular Hypertension 98
Sep 20, 2013: Santen Announced Approval for TAPCOM Combination Ophthalmic Solution for the Treatment of Glaucoma and Ocular Hypertension 99
Jun 07, 2013: Zeltia announces that subsidiary Sylentis has attained the primary endpoint of the Phase IIa clinical trial with its compound SYL040012. 99
May 03, 2013: Amakem To Present Additional Data On AMA0076 At ARVO Annual Meeting 100
Jan 18, 2013: Santen Pharma Receives Japanese Approval For Tapros Mini Ophthalmic Solution 0.0015% For Glaucoma And Ocular Hypertension Treatment 100
Appendix 101
Methodology 101
Coverage 101
Secondary Research 101
Primary Research 101
Expert Panel Validation 101
Contact Us 101
Disclaimer 102
【レポート販売概要】
■ タイトル：高眼圧症(Ocular Hypertension)：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Ocular Hypertension - Pipeline Review, H1 2015
■ 発行日：2015年2月24日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6270IDB
■ 調査対象地域：グローバル
- 代謝性アシドーシス（Metabolic Acidosis）：グローバル臨床試験レビュー（2014年上半期）Metabolic Acidosis Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metabolic Acidosis Global Clinical Trials Review, H1, 2014" provides data on the Metabolic Acidosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metabolic Acidosis. It includes an overview of the trial numbers and their recruitme …
- 世界の大砲及びシステム市場2015-2025Summary Global spending on artillery and systems is expected to register a CAGR of 3.64% over the forecast period, primarily due to the procurement anticipated by major defense spending countries that are currently involved in conflicts, and emerging economies involved in territorial disputes and countering insurgencies. In addition, the need to maintain a sufficient inventory of second line of fi …
- 世界の主変圧器市場動向（2014-2018）TechNavio's analysts forecast the Global Traction Transformer market to grow at a CAGR of 7.30 percent over the period 2014-2018. One of the key factors contributing to this market growth is the increasing congestion in road and airways transport. The Global Traction Transformer market has also been witnessing the increase in technological advancements. However, the increasing threat from local ve …
- 液体用カートン（紙容器）の世界市場2015-2019About Liquid Packaging Carton Liquid packaging cartons provide liquid food and drinks with support, protection from the external environment, and resistance from tampering. They also aid in the reliable distribution of liquid products among the value chain and reduce post-production damage. Vendors in the Global Liquid Packaging Carton market take customers' needs into consideration and manufactur …
- 世界のケミカルセンサー市場2015The Global Chemical Sensors Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Chemical Sensors industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Chemical Sensors market analysis is provided for the international markets including development trends, …
- 軍事用外骨格（エクソスケルトンスーツ）の世界市場2017-2021About Military ExoskeletonAn exoskeleton is a wearable that is powered by a system of electric motors, hydraulics, levers, pneumatics, or by a combination of technologies, which enable limb movement with additional strength and endurance limits for the wearer. Technavio’s analysts forecast the global military exoskeleton market to grow at a CAGR of 65.19% during the period 2017-2021. [Covered in t …
- 嫌気消化の世界市場展望2017-20276According to Stratistics MRC, the Global Anaerobic Digestion Market is accounted for $6.45 billion in 2017 and is expected to reach $16.09 billion by 2026 growing at a CAGR of 10.7% during the forecast period. Some of the key factors influencing the market are raising focus toward sustainable energy coupled with measures to reduce greenhouse gas emissions. However, high cost of investment in large …
- 世界の乗用自動車向けタイヤ空気圧警報システム（TPMS）及び車線逸脱警報システム(LDWS)市場The major factors driving the demand of automotive TPMS and LDW system are stringent safety norms, increased safety awareness, technological advancement, affordability as well as institutions such as the New Car Assessment Program (NCAP) awarding safety ratings to cars based on safety performance. In the coming years, the increasing demand for luxury cars in the regions like Europe and Asia Pacifi …
- バス・シャワー用品の世界市場2015-2019Technavios market research analyst predicts the global bath and shower products market to reach a market value of around USD 15 billion by the end of 2019. The increasing awareness about health and hygiene is the primary driver for the growth of this market. Consumers are being exposed to reliable information about the various bath products through the internet, television, and other sources of in …
- Thyroid Cancer：グローバル臨床試験レビューH2, 2013Thyroid Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Thyroid Cancer Global Clinical Trials Review, H2, 2013" provides data on the Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per …
- 企業向けファイル共有・同期（EFSS）アプリケーションの世界市場予測（～2020）The Enterprise File Sharing and Synchronization market size is expected to grow from USD 1.11 Billion in 2015 to USD 3.51 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 25.7%. Composed EFSS trend, demand for cloud-based integration, and Bring-Your-Own-Device (BYOD) adoption have enabled wider adoption of EFSS solutions among many industries. Companies are increasingly adopting EFSS so …
- 世界のデータセンター建設市場動向（2014～2018）TechNavio's analysts forecast the Global Data Center Construction market to grow at a CAGR of 21.99 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing demand for data center colocation services. The Global Data Center Construction market has also been witnessing the adoption of green data center facilities. However, the introduction of conta …
- アイウェアの世界市場：コンタクトレンズ、サングラス、メガネAbout Eyewear Eyewear enhances vision and corrects eye defects such as myopia, presbyopia, and astigmatism. Eye defects are widely prevalent and demand for corrective eyewear is on the rise.It is also used for protecting the eyes from sunlight or dust, as well as for aesthetic appeal. Eyewear can be categorized as prescription eyewear, non-prescription eyewear, and others. Technological advancemen …
- 世界のロボット手術市場：Global Robotic Surgery Market 2014-2018TechNavio's analysts forecast the Global Robotic Surgery market to grow at a CAGR of 11.65 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in the aging population. The Global Robotic Surgery market has also been witnessing the increase in automation. However, the high cost could pose a challenge to the growth of this market. TechNavio's …
- バグ追跡ソフトウェアの世界市場：展開別、組織規模別、業種別Bug tracking software enables to detect bugs in software projects, resolve them, and ensure to have contingency & preventive measures with the purpose of not repeating the detected bugs in the future projects. It allows individuals or groups of developers to keep a track of unresolved bugs in the product effectively and maintain a database of problem reports. Apart from tracking bugs, it can submi …
